AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 41,450
-1,650 (-3.83%)
At close: Jun 12, 2026
AprilBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -10,121 | -9,728 | 20,005 | -14,130 | -8,959 | -52,713 |
Depreciation & Amortization | 672.5 | 689.55 | 706.33 | 674.42 | 593.44 | 487.25 |
Loss (Gain) From Sale of Assets | - | - | 0 | 25.87 | 0.01 | - |
Loss (Gain) From Sale of Investments | 658.95 | 658.95 | - | - | - | - |
Stock-Based Compensation | 822.3 | 1,136 | 2,127 | 959.84 | 378.87 | 523.33 |
Other Operating Activities | 2,917 | 4,054 | -637.92 | 3,604 | -1,073 | 57,119 |
Change in Accounts Receivable | 2,172 | - | - | - | 4,292 | -4,276 |
Change in Income Taxes | -225.76 | -181.15 | 94.9 | -264.71 | -159.89 | -15.57 |
Change in Other Net Operating Assets | -961.96 | 28.29 | -335.54 | -928.88 | -1,776 | 2,127 |
Operating Cash Flow | -4,066 | -3,342 | 21,960 | -10,059 | -6,704 | 3,252 |
Capital Expenditures | -228.35 | -287.84 | -445.29 | -511.97 | -89.59 | -705.82 |
Sale (Purchase) of Intangibles | -218 | - | - | - | - | - |
Investment in Securities | 5,657 | 5,893 | -22,345 | -6,500 | -31,500 | -23,000 |
Other Investing Activities | 27.11 | 0.11 | -6.72 | -41.77 | -52.13 | -93.69 |
Investing Cash Flow | 5,238 | 5,605 | -22,797 | -7,054 | -31,642 | -23,800 |
Long-Term Debt Issued | - | - | - | 14,848 | - | - |
Long-Term Debt Repaid | - | -362.24 | -329.98 | -291.45 | -248.24 | -161.81 |
Net Debt Issued (Repaid) | -358.91 | -362.24 | -329.98 | 14,556 | -248.24 | -161.81 |
Issuance of Common Stock | 2,791 | 1,848 | 1,098 | 1,755 | 20,577 | 24,955 |
Other Financing Activities | -10.34 | -10.34 | -3,281 | -0 | -0 | -0 |
Financing Cash Flow | 2,421 | 1,475 | -2,513 | 16,312 | 20,328 | 34,793 |
Foreign Exchange Rate Adjustments | 92.13 | -12.07 | 110.51 | 103.16 | 924.37 | - |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | 0 | - |
Net Cash Flow | 3,686 | 3,726 | -3,240 | -697.32 | -17,093 | 14,245 |
Free Cash Flow | -4,294 | -3,630 | 21,514 | -10,571 | -6,794 | 2,546 |
Free Cash Flow Margin | -591.99% | -167.14% | 78.19% | - | -3396.76% | 10.88% |
Free Cash Flow Per Share | -190.57 | -160.22 | 981.88 | -495.25 | -347.29 | 305.34 |
Levered Free Cash Flow | -8,403 | -8,389 | 2,492 | 4,066 | -4,137 | -18,335 |
Unlevered Free Cash Flow | -8,129 | -8,002 | 3,380 | 4,648 | -4,119 | -17,014 |
Change in Working Capital | 984.28 | -152.86 | -240.64 | -1,194 | 2,356 | -2,164 |